Concepts in the prevention and management of malignant hyperthermia.
Collins
Chad P
CP
Department of Oral and Maxillofacial Surgery, School of Dentistry, University of Washington, Seattle, WA 98195, USA.
Beirne
O Ross
OR
D006801:Humans; D008305:Malignant Hyperthermia / Q000517:prevention & control* / Q000628:therapy; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects
D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine